PathogenicLDLR variants, especially in the homozygous state, portend a greatly elevated and early-onset CVD risk, necessitating vigilant management and family screening APOB and PCSK9 variants contribute to hypercholesterolemia as well, but their association with clinical CVD appears weaker. This evidence concerns the gene APOB and familial hypercholesterolemia.